There are currently no events to display.
Webinars
Jun 16, 2022
6:00 PM CEST
The Potential of Prosigna
We invite you to join this live and interactive webinar designed for doctors treating breast cancer interested in advancing personalized treatment through molecular gene expression testing.
- Understand the potential of Prosigna
- Discuss the advantages of using a second-generation genomic test
- Learn about the utility of intrinsic subtyping in the clinic
Live discussion and debates looking at the past, present and future.
PROSIGNA®
Conferences
Jun 11, 2022
(June 11-14)
Endocrine Society (ENDO) 2022
Atlanta, Georgia
Join us at ENDO 2022, Booth #1238, and learn how Afirma genomic testing can help you confidently guide surgery and treatment decisions for patients with thyroid nodules.
AFIRMA®
Conferences
Jun 3, 2022
(June 3-7)
American Society of Clinical Oncology (ASCO)
Chicago, Illinois
Visit us at booth #21085 to learn more about Veracyte's portfolio of diagnostic products.
If you would like to book a meeting to meet with the Veracyte team at ASCO, please submit a request and we will be in touch:
BOOK A MEETING
AFIRMA®
DECIPHER®
IMMUNOSCORE®
PERCEPTA®
PROSIGNA®
Conferences
May 24, 2022
(May 22-24)
American Association of Endocrine Surgeons (AAES)
Cleveland, Ohio
Visit us at the AAES meeting and learn how Afirma genomic testing can help you confidently guide surgery and treatment decisions for patients with thyroid nodules. We will be available at booth #102 to answer any questions. If you would like to book a meeting with the Afirma team, you can submit a request using the link below and we will be in touch.
Book a meeting
Veracyte has also sponsored an on demand webinar. Listen as Joshua Klopper, MD discusses the clinical performance of the Afirma Genomic Sequencing Classifier and how it can help optimize thyroid nodule management. The webinar can be accessed using the link below:
Clinical Performance of the Afirma Genomic Sequencing Classifier: Real World Experience and the Optimization of Thyroid Nodule Management
AFIRMA®
Conferences
May 16, 2022
(May 13-18)
American Thoracic Society (ATS)
San Franscisco, California
Visit us at Booth 1908 to learn about our genomic diagnostic tests of interstitial lung disease and lung cancer. LEARN MORE
Join our ATS Industry Theaters
- Tuesday, May 17, 12:30-1:00pm - Integrating Novel Genomic Data to Improve ILD Dagnositc and Prognostic Confidence
- Tuesday, May 17, 1:30-2:00pm - Integrating the Percepta Genomic Sequencing Classifier for Lung Nodules and Risk Stratification
Data Presentation
- Monday, May 16, 9:30-11:00am - Poster #217: A Nasal Genomic Classifier for Assessing Risk of Malignancy In Lung Nodules Demonstrates Similar Performance In Patients that Meet Screening Criteria for High Baseline Risk and Those Who Do Not
PERCEPTA®
ENVISIA®
Conferences
May 13, 2022
(May 13-18)
American Association of Clinical Endocrinology (AACE)
San Diego, California
Visit us at the AACE meeting and learn how Afirma genomic testing can help you confidently guide surgery and treatment decisions for patients with thyroid nodules.
Data Presentations
- Saturday, May 14, 10:10am - Dorota Whitmer, MD will present a poster titled “Malignancy Risk Associated with the Thyroid Stimulating Hormone Receptor (TSHR) pI568T Variant in Bethesda III/IV Thyroid Nodule Cytology”
- Saturday May 14, 12:30pm - Joshua Klopper, MD will present “Clinical Performance of the Afirma Genomic Sequencing Classifier: Real World Experience and the Optimization of Thyroid Nodule Management”
Additional opportunities to engage with the Afirma team
- Friday May 13 Cocktail Reception, 5:00-7:00pm in the Presidential Suite (#3001) of the AACE conference hotel, the Hilton San Diego Bayfront, as we celebrate the impact of molecular testing on patients with thyroid nodules - Create a reminder on your calendar
- If you would like to book a meeting with the Afirma team, please submit a request we will be in touch. Book a meeting
AFIRMA®
Conferences
May 3, 2022
ESMO Breast 2022
Berlin, Germany
Visit us at ESMO Breast 2022 to learn more about how Prosigna provides more comprehensive information combining tumor gene expression, clinico-pathological factors and intrinsic subtypes to better inform treatment decisions.
PROSIGNA®
Conferences
Apr 29, 2022
April 27-28
American Association of Head and Neck Surgery (AHNS) Annual Meeting
Dallas, Texas
Visit us at the AHNS annual meeting and learn how Afirma genomic testing can help you confidently guide diagnosis, and guide surgery and treatment decisions for patients with thyroid nodules.
We will be available at booth #501 to answer any questions.
AFIRMA®
Webinars
Apr 1, 2022
ON DEMAND
ATA Webinar: The Role of Tumor Genotyping in Thyroid Module Patient Management
A new on-demand webinar, sponsored by Veracyte, is available via the American Thyroid Association (ATA). Watch as a multidisciplinary panel from leading institutions across the country discusses the expanding role of tumor genotyping in thyroid nodule patient management. This discussion, led by Dr. Paul Ladenson, features several real-world case studies from the perspectives of an endocrinologist, surgeon, and pathologist.
AFIRMA®
Conferences
Oct 17, 2021
CHEST 2021
Visit the Veracyte virtual booth at this year’s CHEST 2021 annual meeting. The American College of Chest Physicians (CHEST) is the global leader in advancing best patient outcomes through innovative chest medicine education, clinical research, and team-based care.
PERCEPTA®
ENVISIA®
Conferences
Jun 4, 2021
ASCO 2021
Visit the Veracyte virtual booth at this year's ASCO conference. The 2021 ASCO Annual Meeting will feature a dynamic program of educational and scientific sessions, showcasing what is possible when the cancer care community comes together to advance cancer research, treatment, and patient care.
AFIRMA®
PERCEPTA®
ENVISIA®
PROSIGNA®
Conferences
May 14, 2021
ATS 2021
Visit the Veracyte virtual booth at this year's ATS conference. ATS 2021 showcases the latest advances and discoveries in respiratory science, patient care and global respiratory health. At a unique moment in history, these breakthroughs will shape our future as scientists, healthcare professionals and leaders in the field.
PERCEPTA®
ENVISIA®
Webinars
Mar 31, 2021
6:30 PM ET / 3:30 PM PT
ATS Industry Innovations Webinar
Join us for a live webinar discussing the gaps in the lung cancer diagnosis and care continuum and the transformative role of novel genomic tests, such as a non-invasive nasal swab for early lung cancer detection and a comprehensive genomic profiling test for more informed treatment decision making.
PERCEPTA®
Webinars
Mar 15, 2021
Molecular Markers/Thyroid Nodules E-Product Theater
Recently presented during the American Thyroid Association's Year in Thyroidology event, Dr. Erik Alexander reviews the latest evidence suggesting molecular markers have prognostic significance in informing tumor phenotype and behavior.
AFIRMA®
Conferences
Dec 8, 2020
Virtual Event
San Antonio Breast Cancer Virtual Symposium
PROSIGNA®
Webinars
Nov 9, 2020
6:30 PM ET / 3:30 PM PT
ATS Webinar: Hot Topics in ILD Diagnosis: MDD, Genomics and PF ILD
This interactive session covers the key elements of an MDD, the role of the Envisia genomic classifier, and the identification of progressive fibrosing ILD.
ENVISIA®
Conferences
Oct 29, 2020
Go2 Foundation Centers of Excellence Virtual Summit
Visit the Veracyte virtual booth at this year's Summit. The virtual Summit will showcase how Centers of Excellence (COEs) are leading in areas of early detection and multidisciplinary treatment of lung cancer as well as creating valuable opportunities for virtual collaboration and networking over two exciting days.
PERCEPTA®
Webinars
Oct 17, 2020
On Demand
CHEST Virtual Learning Theater: Improving Lung Cancer and ILD Diagnostic Confidence with Percepta and Envisia Classifiers
Experts review how the Percepta and Envisia genomic classifiers help improve confidence in lung disease diagnosis and share how the tests integrate into their patient management.
PERCEPTA®
ENVISIA®
Webinars
Sep 25, 2020
4:00 PM CEST / 7:00 AM PT
Genomic Profiling and the Future of Early Breast Cancer Care
Clinical experts discuss biomarker strategies, emerging treatments, and interdisciplinary methods using the Prosigna® breast cancer prognostic gene signature for patient management.
PROSIGNA®
Webinars
Sep 24, 2020
7:30 PM ET / 4:00 PM PT
Envisia Genomic Classifier Utility in ILD Diagnosis and Prognosis
A panel of experts will review new clinical data recently published in
AJRCCM and discuss how the Envisia classifier integrates into their ILD patient management.
ENVISIA®
Webinars
Sep 18, 2020
11:25 PM ET / 8:25 AM PT
Improving Lung Cancer and ILD Diagnostic Confidence with Percepta and Envisia Classifiers
AABIP Sponsored Session
PERCEPTA®
ENVISIA®
Webinars
Sep 9, 2020
6:00 PM ET / 3:00 PM PT
Real-World Lung Nodule Management During COVID-19
In times of COVID-19 the management of lung nodules has become even more challenging. Join your peers to hear the latest updates in lung nodule management and how to implement these into clinical practice.
PERCEPTA®